TSI, DrFirst Collaborate
News Dec 01, 2016
Translational Software® Inc (TSI) has announced that the company has been selected by DrFirst to enable pharmacogenomics (PGx)-based e-prescribing within the Rcopia® medication management system at the point of care. The partnership will offer Rcopia’s 330+ electronic health record and hospital information system vendors and 62,000 providers a comprehensive solution for prescribing safer and more effective medications based on a patient’s genetic makeup.
TSI’s proprietary knowledge platform and Application Programming Interface (API) will provide genotyping prompts, genomic decision support and critical alerts regarding drug efficacy, toxicity and known interactions within the e-prescribing workflow to guide clinical decision making, minimize adverse reactions and enable physicians to prescribe the most effective medications in real-time. The PGx results can be used throughout the patient’s lifetime to improve treatment decisions and overall population health outcomes. Ordering and reporting will be delivered through Rcopia’s medication adherence tool, Patient Advisor℠.
“Integrating Translational Software’s PGx knowledge base within our e-prescribing platform allows us to deliver an in-workflow, evidence-based approach to medication prescribing that can be used as part of routine care,” stated G. Cameron Deemer, president of DrFirst. “In addition, the API will allow us to cost-effectively scale our efforts and develop a customized, seamless clinician experience for accessing genomic data within Rcopia.”
Developed using the Fast Healthcare Interoperability Resources (FHIR) specification, the API will enable Rcopia’s extensive user base to:
•Identify patients as candidates for genotyping based on the medication being prescribed
•Order recommended PGx tests through Exceltox and Alpha Genomix laboratories
•Review detailed reports that identify potential drug-gene and drug-drug interactions and adverse events, and provide medication alternatives
•Access genetic test results to flag interactions for future medications over the patient’s lifetime
DrFirst’s Rcopia is the leading platform for drug e-prescribing and controlled substance e-prescribing, electronic prior authorization, medication history and medication adherence. It is also the first system in the industry to provide real-time benefit checking to guide cost-effective prescription decisions.
“We have a significant opportunity to drive value-based healthcare throughout the U.S. by eliminating costly and ineffective therapies through use of a genomic e-medication management system at such a large scale,” stated Don Rule, CEO, TSI. “We are very excited to be working with DrFirst to develop an IT infrastructure that makes it possible to improve treatment decisions by providing timely, accessible and actionable genomic information to clinicians as part of their existing workflow.” TSI’s PGx knowledge base and genomic decision support is expected to be available in Rcopia in the first quarter of 2017.
Source: Story from Translational Software® Inc. Please note: The content above may have been edited to ensure it is in keeping with Technology Networks' style and length guidelines.
Algorithm Speeds Up Medical Image Analysis 1000 TimesNews
Medical image registration is a common technique that involves overlaying two images, such as magnetic resonance imaging (MRI) scans, to compare and analyze anatomical differences in great detail. Researchers have described a machine-learning algorithm that can register brain scans and other 3-D images more than 1,000 times more quickly using novel learning techniques.
Antarctic Worm and Machine Learning Help Identify Cerebral Palsy EarlierNews
A research team has released a study in the peer-reviewed journal BMC Bioinformatics showing that DNA methylation patterns in circulating blood cells can be used to help identify spastic cerebral palsy (CP) patients. The technique which makes use of machine learning, data science and even analysis of Antarctic worms, raises hopes for earlier targeted CP therapies.
Towards Personalized Medicine: One Type of Data is Not EnoughNews
To understand the biology of diseased organs researchers use different types of molecular data. One of the biggest computational challenges at the moment is integrating these multiple data types. A new computational method jointly analyses different types of molecular data and disentangles the sources of disease variability to guide personalized treatment.READ MORE